SEARCH RESULTS FOR: "Tag: MNK"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(2)
ARTICLES/BLOGS
2019(2)
2018(3)
2017(7)
2016(13)
2015(6)
CATEGORIES
Analyst Update(5)
Analyst Upgrades(1)
Buzz Stocks(4)
By the Numbers(2)
Expectational Analysis(1)
Indexes and ETFs(1)
Indicator of the Week(1)
Intraday Option Activity(6)
Market Recap(1)
Midday Market Check(1)
Opening View(2)
Stock Market News(7)
Stocks On the Move(13)
Unusual Trading Activity(1)

5/21/2019 10:07 AM
Two drug names are sitting at the bottom of the Nasdaq and NYSE this morning. First, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is down 51.3% to trade at $3.60, and earlier tapped a new two-and-a-ha...
4/30/2019 2:11 PM
The U.S. stock market is dragging today on a rare revenue miss from Google parent Alphabet (GOOGL). Among other names making notable moves are former Dow component General Electric Company (NYSE:GE)...
12/12/2018 9:26 AM
Dow Jones Industrial Average (DJIA) futures are trading more than 200 points above fair value, after President Donald Trump chimed in on last week's arrest of Chinese tech exec Meng Wanzhou -- who w...
9/11/2018 9:54 AM
Mallinckrodt PLC (NYSE:MNK) stock is down 5.2% to trade at $31.30 this morning, after Goldman Sachs downgraded the pharmaceutical concern to "sell" from "neutral." While the analyst in coverage upped ...
4/12/2018 2:34 PM
Pharmaceutical concern Mallinckrodt PLC (NYSE:MNK) stock is plummeting today, down 9% to trade at $13.44, and earlier touching a record low of $13.32. Sending the drug stock lower is a Business Ins...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center